// App-Quantinova.ai

489 : Busulfan-Based Allogeneic Hematopoietic Cell Transplantation with Various Donor Type Including Haploidentical Familial Mismatched Donor as Post-Remission Therapy in Adult Acute Lymphoblastic Leukemia

Researchers

Presenter

  • Dae-Young Kim

Principal Investigators

  • Han-Seung Park

  • Eunji Choi

  • Je-Hwan Lee

  • Jung-Hee Lee

  • Mijin Jeon

  • Young-Shin Lee

  • Young-Ah Kang

  • Kyoo-Hyung Lee

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Acute lymphoblastic leukemia

  • Graft-versus-host disease

Biomarkers

  • Breakpoint Cluster Region

  • Cluster of Differentiation 34

  • Soluble Complement 5b-9

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • fludarabine tablet

  • Busulfan

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved